What does PHARMACIE DU RING do?

PHARMACIE DU RING is a pharmacy in Châtelet. Private Limited, started on 20 March 2008, 1 establishment.

What is the address of PHARMACIE DU RING?

The registered office of PHARMACIE DU RING is located at Rue de la Station 191, 6200 Châtelet.

Is PHARMACIE DU RING still active?

Yes. According to the CBE (18 September 2026) PHARMACIE DU RING is active, legal situation “Normale toestand”, started on 20 March 2008.

Is PHARMACIE DU RING registered on Peppol?

Yes, PHARMACIE DU RING is registered on the Peppol network with ID 0208:0896600296.

What is the enterprise number of PHARMACIE DU RING?

The enterprise number of PHARMACIE DU RING is BE0896600296.

When was PHARMACIE DU RING founded?

PHARMACIE DU RING was founded on 20 March 2008.

Who are the directors of PHARMACIE DU RING?

According to the 2025 annual accounts, the directors of PHARMACIE DU RING are: GESTIPHAR SRL.

Is PHARMACIE DU RING a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 March 2008; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE DU RING make in 2025?

PHARMACIE DU RING posted a profit after taxes of € 82,329 in financial year 2025.

What is the revenue of PHARMACIE DU RING?

As a small company, PHARMACIE DU RING is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 270,858.

How much does an employee at PHARMACIE DU RING earn?

The average wage cost per full-time employee at PHARMACIE DU RING was € 67,400 in 2025: staff costs of € 80,919 for 1.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE DU RING have?

According to the 2025 annual accounts, PHARMACIE DU RING has 1.2 full-time equivalents (FTE).

PHARMACIE DU RING (Private Limited) - Châtelet

Dossier PHARMACIE DU RING, printed on 18 September 2026 from databakkes.be/en/0896600296/pharmacie-du-ring. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE DU RING from Châtelet, company number BE0896600296, closed financial year 2025 with a result of € 82,329 after tax. For that financial year PHARMACIE DU RING recorded a gross margin of € 270,858 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 68,902 to € 82,329. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 30, 2025.

What it is worth Growing

€ 1.3 million

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 82,329

▲ 19% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 337,741

▲ 2% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.3 million.

People and assets in 2025

Full-time equivalents

1.2

▼ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 80,919

▼ 8% vs 2024

€ 67,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 8,344

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 198,246

▼ 27% vs 2024

€ 80,901 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 175,442

▼ 15% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 16,278

▼ 30% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 434,495 Gross margin 2022: € 434,495 First fiscal year in the series	€ 268,025 Gross margin 2023: € 268,025 ▼ 38% vs 2022 (€ 434,495) Unfavourable step	€ 257,172 Gross margin 2024: € 257,172 ▼ 4% vs 2023 (€ 268,025) Unfavourable step	€ 270,858 Gross margin 2025: € 270,858 ▲ 5% vs 2024 (€ 257,172) Favourable step	▲ 5%
Profit after taxes	€ 170,901 Profit after taxes 2022: € 170,901 First fiscal year in the series	€ 72,053 Profit after taxes 2023: € 72,053 ▼ 58% vs 2022 (€ 170,901) Unfavourable step	€ 68,902 Profit after taxes 2024: € 68,902 ▼ 4% vs 2023 (€ 72,053) Unfavourable step	€ 82,329 Profit after taxes 2025: € 82,329 ▲ 19% vs 2024 (€ 68,902) Favourable step	▲ 19%
Equity	€ 1,045,954 Equity 2022: € 1,045,954 First fiscal year in the series	€ 1,118,007 Equity 2023: € 1,118,007 ▲ 7% vs 2022 (€ 1,045,954) Favourable step	€ 1,186,909 Equity 2024: € 1,186,909 ▲ 6% vs 2023 (€ 1,118,007) Favourable step	€ 1,269,238 Equity 2025: € 1,269,238 ▲ 7% vs 2024 (€ 1,186,909) Favourable step	▲ 7%
Total debts	€ 566,905 Total debts 2022: € 566,905 First fiscal year in the series	€ 565,718 Total debts 2023: € 565,718 Unchanged (€ 566,905) Favourable step	€ 506,901 Total debts 2024: € 506,901 ▼ 10% vs 2023 (€ 565,718) Favourable step	€ 395,908 Total debts 2025: € 395,908 ▼ 22% vs 2024 (€ 506,901) Favourable step	▼ 22%
Cash	€ 437,762 Cash 2022: € 437,762 First fiscal year in the series	€ 311,242 Cash 2023: € 311,242 ▼ 29% vs 2022 (€ 437,762) Unfavourable step	€ 331,590 Cash 2024: € 331,590 ▲ 7% vs 2023 (€ 311,242) Favourable step	€ 337,741 Cash 2025: € 337,741 ▲ 2% vs 2024 (€ 331,590) Favourable step	▲ 2%
Land & buildings	€ 758,768 Land & buildings 2022: € 758,768 First fiscal year in the series	€ 724,987 Land & buildings 2023: € 724,987 ▼ 4% vs 2022 (€ 758,768) Unchanged	€ 690,358 Land & buildings 2024: € 690,358 ▼ 5% vs 2023 (€ 724,987) Unchanged	€ 663,462 Land & buildings 2025: € 663,462 ▼ 4% vs 2024 (€ 690,358) Unchanged	▼ 4%
Retained profit	€ 1,039,754 Retained profit 2022: € 1,039,754 First fiscal year in the series	€ 1,111,807 Retained profit 2023: € 1,111,807 ▲ 7% vs 2022 (€ 1,039,754) Favourable step	€ 1,180,709 Retained profit 2024: € 1,180,709 ▲ 6% vs 2023 (€ 1,111,807) Favourable step	€ 1,263,038 Retained profit 2025: € 1,263,038 ▲ 7% vs 2024 (€ 1,180,709) Favourable step	▲ 7%
Bank debt	€ 491,988 Bank debt 2022: € 491,988 First fiscal year in the series	€ 380,879 Bank debt 2023: € 380,879 ▼ 23% vs 2022 (€ 491,988) Favourable step	€ 272,693 Bank debt 2024: € 272,693 ▼ 28% vs 2023 (€ 380,879) Favourable step	€ 198,246 Bank debt 2025: € 198,246 ▼ 27% vs 2024 (€ 272,693) Favourable step	▼ 27%
Balance sheet total	€ 1,612,859 Balance sheet total 2022: € 1,612,859 First fiscal year in the series	€ 1,683,725 Balance sheet total 2023: € 1,683,725 ▲ 4% vs 2022 (€ 1,612,859) Unchanged	€ 1,693,810 Balance sheet total 2024: € 1,693,810 ▲ 1% vs 2023 (€ 1,683,725) Unchanged	€ 1,665,147 Balance sheet total 2025: € 1,665,147 ▼ 2% vs 2024 (€ 1,693,810) Unchanged	▼ 2%
Employees (FTE)	1.7 Employees (FTE) 2022: 1.7 First fiscal year in the series	1.7 Employees (FTE) 2023: 1.7 Unchanged (1.7) Unchanged	1.7 Employees (FTE) 2024: 1.7 Unchanged (1.7) Unchanged	1.2 Employees (FTE) 2025: 1.2 ▼ 0.5 vs 2024 (1.7) Unchanged	▼ 0.5

Key figures of PHARMACIE DU RING, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.

What happened to PHARMACIE DU RING?

What happened at PHARMACIE DU RING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 30, 2025 New annual accounts for financial year 2025: profit of € 82,329 (▲ 19% vs 2024). Source: NBB ↗
Mar 20, 2008 New establishment in Châtelet. KBO
Mar 20, 2008 Start of the company according to the CBE. KBO

In short

From € 170,901 profit in 2022 to € 82,329 profit in 2025.

Paid € 183,884 in corporate taxes since 2022.

Best year ever: 2022, with € 170,901 profit.

On average € 225,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE DU RING? We notify you, reason included.

Follow PHARMACIE DU RING

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit